January 6, 2013 ePRO Systems Validation: Clearly Defining The Roles Of Clinical Trial Teams And ePRO System Providers
May 30, 2013 Identifying Combinatorial Biomarkers by Association Rule Mining in the CAMD Alzheimer’s Database
May 29, 2013 Qualitative Development and Cognitive Evaluation of the Symptoms of Major Depressive Disorder (S-MDD), A Consortium-Developed Patient Reported Outcome Measure
May 13, 2013 Alignment of New Tuberculosis Drug Regimens and Drug Susceptibility Testing: A Framework for Action
January 5, 2013 Tuberculosis Comorbidity with Communicable and Non-Communicable Diseases: Integrating Health Services and Control Efforts
March 24, 2013 Advances in Tuberculosis Diagnostics: The Xpert MTB/RIF Assay and Future Prospects for a Point-of-Care Test
March 2, 2013 Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium
March 1, 2013 The advantages of frontotemporal degeneration drug development (Part 2 of frontotemporal degeneration: the next therapeutic frontier)
